Trial Profile
A Randomized Phase-II Pilot Trial of Docetaxel and Prednisone Versus Radiation Therapy Plus Docetaxel and Prednisone in Patients With Nonmetastatic and Oligometastatic Castrate Resistant Prostate Cancer.
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Docetaxel (Primary) ; Prednisone (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 18 Oct 2011 Actual initiation date (Mar 2011) added as reported by ClinicalTrials.gov.
- 18 Oct 2011 Planned End Date changed from 1 Mar 2015 to 1 Jul 2011 as reported by ClinicalTrials.gov.
- 18 Oct 2011 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.